Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets cancer cells…
Tumor boards are an invaluable tool to share knowledge and ensure optimal treatment for people with cancer. The conversations that occurred in the hallways outside those disease-focused panels, however, prompted Alan Alper Sag, MD, FSIR,…
Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the recurrence rate…
Preliminary research published in Nature suggests that COVID-19 vaccines, particularly Pfizer and Moderna, may offer unexpected benefits for cancer patients. People with advanced lung or skin cancer who received the vaccine within 100 days…
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer…
An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of various tumor types.
Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory conditions. For many, it has provided relief when other therapies failed.
The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the effectiveness of immunotherapy in cancer patients. Widespread use of the vaccine could lead to better medical…
The service, set for a pilot, would see patients assessed as high risk immediately sent to a radiologist before an on-the-spot biopsy. Pictured: File photo of current prostate cancer test
It’s a promising medical discovery that could help researchers fight cancer. New research published in the journal Nature has found that patients with some forms of advanced cancer who received a COVID mRNA vaccine lived significantly…
Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard immunotherapy, treatment options are painfully limited. Vanderbilt researchers led by Professor Emerita of…
Sometimes the unintended consequences of a treatment can seem worse than the disease. That's certainly the case for patients who develop chemotherapy-induced cardiotoxicity—a severe side-effect that can lead to heart failure and the…
"These changes ensure no breast cancer patient is left behind when it comes to accessing the best possible reconstructive care," said C. Bob Basu, MD, MBA, MPH, president of ASPS. "This legislation empowers patients with the reconstruction…
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and an immune checkpoint inhibitor—can…